ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

5'-Phospho-2'-deoxyribocytidylylriboadenosine → (2R,3S,4R,5R)-2-((((((2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-((phosphonooxy)methyl)tetrahydrofuran-3-yl)oxy)(hydroxy)phosphoryl)oxy)methyl)-5-(6-amino-9H-purin-9-yl)-4-hydroxytetrahydrofuran-3-yl 2-(N-methylpent-4-enamido)acetate

HRID 1482382
印刷

反応式

HRID 1482382 の反応式
[P:1]([O:5][CH2:6][C@@H:7]1[C@@H:11]([O:12][P:13]([O:16][CH2:17][C@@H:18]2[C@@H:22]([OH:23])[C@@H:21]([OH:24])[C@H:20]([N:25]3[CH:33]=[N:32][C:31]4[C:26]3=[N:27][CH:28]=[N:29][C:30]=4[NH2:34])[O:19]2)([OH:15])=[O:14])[CH2:10][C@H:9]([N:35]2[CH:40]=[CH:39][C:38]([NH2:41])=[N:37][C:36]2=[O:42])[O:8]1)([OH:4])([OH:3])=[O:2].C([N+](CCCC)(CCCC)CCCC)CCC.P(OC[C@@H]1[C@@H](OP(OC[C@@H]2[C@@H](O)[C@@H](O)[C@H](N3C=NC4C3=NC=NC=4N)O2)(O)=O)C[C@H](N2C=CC(N)=NC2=O)O1)(O)(O)=O.[CH3:102][N:103]([CH2:110][C:111](OCC#N)=[O:112])[C:104](=[O:109])[CH2:105][CH2:106][CH:107]=[CH2:108]>O1CCCC1>[CH3:102][N:103]([CH2:110][C:111]([O:23][C@H:22]1[C@@H:21]([OH:24])[C@H:20]([N:25]2[CH:33]=[N:32][C:31]3[C:26]2=[N:27][CH:28]=[N:29][C:30]=3[NH2:34])[O:19][C@@H:18]1[CH2:17][O:16][P:13]([O:12][C@H:11]1[CH2:10][C@H:9]([N:35]2[CH:40]=[CH:39][C:38]([NH2:41])=[N:37][C:36]2=[O:42])[O:8][C@@H:7]1[CH2:6][O:5][P:1]([OH:4])([OH:3])=[O:2])([OH:15])=[O:14])=[O:112])[C:104](=[O:109])[CH2:105][CH2:106][CH:107]=[CH2:108]
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 1955115'-Phospho-2'-deoxyribocytidylylriboadenosineHCID 89668754cyanomethyl 2-(N-methylpent-4-enamido)acetateHCID 117735960((2R,3S,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3-(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)tetrahydrofuran-2-yl)methyl dihydrogenphosphate tetrabutylammonium salt2 回

生成物 1

HCID 89668667
(2R,3S,4R,5R)-2-((((((2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-((phosphonooxy)methyl)tetrahydrofuran-3-yl)oxy)(hydroxy)phosphoryl)oxy)methyl)-5-(6-amino-9H-purin-9-yl)-4-hydroxytetrahydrofuran-3-yl 2-(N-methylpent-4-enamido)acetate
収率 11.2%

試薬・触媒・溶媒 1

HCID 8028Tetrahydrofuran溶媒

実験手順

((2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)tetrahydrofuran-2-yl)methyl dihydrogenphosphate (Compound 1h) (Compound 1h) (1.00 g, 1.57 mmol) was dissolved in buffer A (1 l), a solution of cyanomethyl 2-(N-methylpent-4-enamido)acetate (Compound SP704) (2.00 g, 9.51 mmol) in tetrahydrofuran (5 ml) was added and the mixture was stirred at room temperature for 30 minutes. The reaction solution was lyophilized, and the resulting residue was purified by reverse-phase silica gel column chromatography (0.5% aqueous trifluoroacetic acid solution/acetonitrile) to afford the title compound (Compound SP705) (139 mg, 11%).

後処理

  1. customthe resulting residue was purified by reverse-phase silica gel column chromatography (0.5% aqueous trifluoroacetic acid solution/acetonitrile)

出典と根拠

ORDレコード
ord-709edf2996ed47e1b8fcc8991a5ec476
出典データセット
uspto-grants-2016_08
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09409952B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート